Brief: Solasia Pharma KK says announcement concerning signing of license and distribution agreement for SP-02
17/08/2018 04:13
Aug 17(Reuters) - Solasia Pharma KK 4597.T
* Says Solasia and HB Human BioScience SAS have entered into
an
exclusive license agreement pertaining the development and
commercialization of SP-02 in Latin America which Solasia holds
the global rights to develop and commercialize and is currently
conducting clinical development in Asia
* The licensed territory to HB includes Colombia, Peru,
Ecuador,
Venezuela, Chile, Panama, Costa Rica, and Guatemala
Source text in Japanese:https://goo.gl/dS5pR5
Further company coverage: 4597.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))